Related Experiment Video
Updated: Sep 28, 2025

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Applications of Nanotechnology-based Approaches to Overcome Multi-drug Resistance in Cancer
Sana Kalave1, Namita Hegde1, Kapil Juvale1
1Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS, V.L. Mehta Road, Vile Parle [W], Mumbai, India.
Abstract:
Cancer is one of the leading causes of death worldwide. Chemotherapy and radiation therapy are the major treatments used for the management of cancer. Multidrug resistance (MDR) is a major hindrance faced in the treatment of cancer and is also responsible for cancer relapse. To date, several studies have been carried out on strategies to overcome or reverse MDR in cancer. Unfortunately, the MDR reversing agents have been proven to have minimal clinical benefits, and eventually, no improvement has been made in therapeutic efficacy to date. Thus, several investigational studies have also focused on overcoming drug resistance rather than reversing the MDR. In this review, we focus primarily on nanoformulations regarded as a novel approach to overcome or bypass the MDR in cancer. The nanoformulation systems serve as an attractive strategy as these nanosized materials selectively get accumulated in tumor tissues, thereby improving the clinical outcomes of patients suffering from MDR cancer. In the current work, we present an overview of recent trends in the application of various nano-formulations, belonging to different mechanistic classes and functionalization like carbon nanotubes, carbon nanohorns, carbon nanospheres, liposomes, dendrimers, etc., to overcome MDR in cancer. A detailed overview of these techniques will help researchers in exploring the applicability of nanotechnologybased approaches to treat MDR.
Insights
Multidrug resistance (MDR) in cancer hinders treatment. This review explores nanoformulations as a promising strategy to overcome MDR by targeting tumors, potentially improving patient outcomes.
Area of Science:
- Oncology
- Nanotechnology
- Drug Delivery
Background:
- Cancer remains a leading global cause of death, with chemotherapy and radiation therapy as primary treatments.
- Multidrug resistance (MDR) significantly impedes cancer treatment efficacy and contributes to cancer relapse.
- Existing MDR reversing agents show limited clinical benefits, necessitating novel therapeutic strategies.
Approach:
- This review focuses on nanoformulations as a novel approach to overcome or bypass MDR in cancer.
- Nanoformulations offer selective accumulation in tumor tissues, enhancing therapeutic outcomes for MDR cancer patients.
- Various nano-formulations, including carbon nanotubes, liposomes, and dendrimers, are discussed for their potential against MDR.
Key Points:
- Nanoformulations represent an attractive strategy for overcoming multidrug resistance in cancer.
- Selective tumor targeting by nanosized materials improves clinical outcomes in MDR cancer.
- Diverse nano-formulation types (e.g., carbon nanotubes, liposomes, dendrimers) are evaluated for MDR treatment.
Conclusions:
- Nano-based approaches offer a promising avenue for treating multidrug-resistant cancers.
- Further research into nanotechnology-based strategies can significantly advance MDR cancer therapy.
- This review provides an overview to aid researchers in exploring nanotechnology applications for MDR cancer.
More Related Videos
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Related Concept Videos
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...